Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma
Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma have?
Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma has 85 citations in the OpenAlex counts ScholarIQ stores.
When was Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma published?
Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma has 2009 year in the ScholarIQ index.
What is the open-access status of Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma?
Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma has closed oa status in the ScholarIQ index.
What is the DOI of Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma?
The DOI for Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma is on the source record.
What is the PMID of Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma?
The PMID for Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma is on the source record.
What is the OpenAlex record for Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma?
The OpenAlex for Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma is on the source record.